Press Releases from Myasthenia Gravis (MG) Therapeutics -Pharma Proff (1 total)
Myasthenia Gravis (MG) Therapeutics Pipeline to Witness Remarkable Growth due to …
MG is a neuromuscular disorder, which weakens muscles by decreasing number of acetylcholine receptors at the neuromuscular junction. The disease becomes prominent during adulthood; but…
Go To Page:
